Mei Chen
Impact in
- Cell Biology top 0.2%
- Skin and Cellular Biology Research
- Rehabilitation top 0.2%
- Wound Healing and Treatments
Papers in
- Cell Biology 75
- Skin and Cellular Biology Research 64
-
- Wound Healing and Treatments 27
- Co-authors
- David T. Woodley (115 shared papers)Wei Li (41 shared papers)Douglas R. Keene (20 shared papers)Jianhua Fan (13 shared papers)Edel A. O’Toole (16 shared papers)Chensheng Alex Lu (3 shared papers)Lawrence S. Chan (9 shared papers)Shengxi Guan (8 shared papers)
- Journals
- Journal of Investigative Dermatology (34 papers)Journal of Biological Chemistry (8 papers)Molecular Therapy (6 papers)Frontiers in Oncology (5 papers)Scientific Reports (5 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Mei Chen
374 papers receiving 13.3k citations
Mei Chen's Hit Papers
Peers
Comparison fields: 5 of 173
- Cell Biology 2.7k
- Rehabilitation 872
- Pathology and Forensic Medicine 1.5k
- Biophysics 317
- Molecular Biology 2.6k
Countries citing papers authored by Mei Chen
This map shows the geographic impact of Mei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Chen more than expected).
Fields of papers citing papers by Mei Chen
This network shows the impact of papers produced by Mei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Chen. The network helps show where Mei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Mei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 395 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1–Positive Endometrial Cancer: Results From the KEYNOTE-028 Study Hit paper breakdown → | 2017 | 419 |
| 2 | A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update Hit paper breakdown → | 2013 | 379 |
| 3 | 1998 | 316 | |
| 4 | 2009 | 315 | |
| 5 | 1985 | 308 | |
| 6 | 2010 | 295 | |
| 7 | 2014 | 254 | |
| 8 | 2007 | 248 | |
| 9 | 2020 | 187 | |
| 10 | 2008 | 186 | |
| 11 | 1997 | 160 | |
| 12 | 2002 | 159 | |
| 13 | 2003 | 159 | |
| 14 | 2016 | 156 | |
| 15 | 2006 | 141 | |
| 16 | 1977 | 133 | |
| 17 | 2014 | 128 | |
| 18 | 1997 | 126 | |
| 19 | 2011 | 122 | |
| 20 | 2012 | 119 |
About Mei Chen
Mei Chen is a scholar working on Cell Biology, Rehabilitation, Pathology and Forensic Medicine, Molecular Biology and Biophysics, having authored 395 papers that have together received 13.8k indexed citations. Recurring topics across this work include Skin and Cellular Biology Research (64 papers), Autoimmune Bullous Skin Diseases (27 papers), Wound Healing and Treatments (27 papers), Heat shock proteins research (19 papers), Cell Image Analysis Techniques (16 papers), Protein Kinase Regulation and GTPase Signaling (10 papers), Cancer-related molecular mechanisms research (7 papers) and TGF-β signaling in diseases (6 papers). The work is most often cited by research in Cell Biology (2.7k citations), Rehabilitation (872 citations), Pathology and Forensic Medicine (1.5k citations), Biophysics (317 citations) and Molecular Biology (2.6k citations). Mei Chen has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include David T. Woodley, Wei Li, Douglas R. Keene, Jianhua Fan, Edel A. O’Toole, Chensheng Alex Lu, Lawrence S. Chan, Shengxi Guan, Daniel Porte and M. Peter Marinkovich. Their work appears in journals such as Journal of Investigative Dermatology, Journal of Biological Chemistry, Molecular Therapy, Frontiers in Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.